Who founded Flow Pharma?

Flow Pharma was founded by Reid Martin Rubsamen, Reid Michael Rubsamen.

How much funding has Flow Pharma raised?

Flow Pharma has disclosed $3.8M raised across 4 rounds.

Where is Flow Pharma headquartered?

Flow Pharma is headquartered in Warrensville Heights, US.

Flow Pharma

Warrensville Heights, US · Delaware corporation

Find your way into Flow Pharma

1,068 people in our graph share verified history with the Flow Pharma team — schools, employers, funds. One of them is your warm intro.

Adrianna Maunlockedknows Reid Rubsamen · together at Massachusetts Institute of Technology (overlapped)

×3knows the team · via Stanford University

×3knows the team · via Massachusetts General Hospital

×2knows the team · via Massachusetts Institute of Technology

×2knows the team · via Stanford University Graduate School of Business

knows the team · via University of California, Berkeley

Biotech

Founders & leadership

Reid Martin Rubsamen inFounder/CEO/Board MemberFounder/CEO at Immunity Project

Reid Michael Rubsamen inFounder/CEO/Board MemberFounder/CEO at Immunity Project

Thomas Brady inBusiness Development Executive2015–2024Thomas Brady served as VP of Business Development at Flow Pharma for nine years, focusing on capital raising and international partnerships for cancer therapies and research. He holds degrees from UC Berkeley and Stanford GSB, and serves as a Venture Partner with the Global Health Impact Fund.

Lester John LloydExecutive

Board

Pamela SteeleBoard director

Anthony TufaroBoard director

Tikoes BlankenbergBoard director

Babatunde OtulanaBoard director

Reported raises · per SEC filings

Form D private placements

$3.8M disclosed across 4 rounds · 2011–2024

▶$225KraisedAug 2024 · 3 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Pamela SteeleDirector
Anthony TufaroDirector
Reid Martin RubsamenExecutive Officer, Director
Tikoes BlankenbergDirector
Babatunde OtulanaDirector

Offering amount: $40M
Amount sold: $225K
First sale: Jul 2024
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$180KraisedNov 2022 · 8 investors · Biotechnology

Rule 506(c)

Officers, directors & promoters on the filing

Gil Van BokkelenExecutive Officer
Reid Martin RubsamenExecutive Officer, Director
Tikoes BlankenbergDirector
Thomas BarnishExecutive Officer
Stephen FarrDirector
Charles Vincent HerstExecutive Officer
Tom BradyExecutive Officer
Pamela SteeleDirector
Babatunde OtulanaDirector

Offering amount: $10.5M
Amount sold: $180K
Finders' fees: $500K
Placement agents: Carleton McKenna Advisors, LLC
First sale: Oct 2022
Incorporated: Corporation, Delaware
Federal exemptions: 06c

Full filing on SEC EDGAR ↗

▶$2.3MraisedFeb 2018 · 42 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Reid Michael RubsamenExecutive Officer, Director
Thomas BradyExecutive Officer
Lester John LloydExecutive Officer, Director

Amount sold: $2.3M
Minimum investment: $5K
Proceeds to insiders: $300K
First sale: Mar 2016
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$1.1MraisedFeb 2018 · 17 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Reid M RubsamenExecutive Officer, Director
Lester J LloydExecutive Officer, Director

Amount sold: $1.1M
Minimum investment: $12.5K
First sale: Apr 2011
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

Radiuspharm8 shared keywordsRadius is a biopharmaceutical company focused on bone health and related therapeutic areas for underserved patient populations. It markets commercial products in the U.S., including TYMLOS (abaloparatide) injection and BINOSTO (alendronate sodium).

Companies competing with Flow Pharma for the same Google search keywords, organic and paid, via search-intersection analysis.

Non-dilutive funding · 2 SBIR/STTR awards

Federal grants — no equity taken

Agency	Phase	Year	Amount
Department of DefenseOffice for Chemical and Biological Defense	Phase IISTTR	2020	$537.5K
Department of DefenseOffice for Chemical and Biological Defense	Phase ISTTR	2018	$136.8K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

In the news

Biotech Flow Pharma, Inc. Announces Formation of China Joint Venture With Investing Partner Button Capitalfinance.yahoo.com · Sep 2018

Frequently asked questions

Who founded Flow Pharma?: Flow Pharma was founded by Reid Martin Rubsamen, Reid Michael Rubsamen.
How much funding has Flow Pharma raised?: Flow Pharma has disclosed $3.8M raised across 4 rounds.
Where is Flow Pharma headquartered?: Flow Pharma is headquartered in Warrensville Heights, US.